Amgen's expenditure on research and development 2006-2022

Published by
Matej Mikulic,
Feb 23, 2023
Amgen's R&D expenses amounted to approximately 4.4 billion U.S. dollars in 2022. This statistic shows the expenditure on research and development of biotech company Amgen from 2004 to 2022. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California.

Amgen's expenditure on research and development from 2006 to 2022 (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2023

Region

Worldwide

Survey time period

2004 to 2022

Supplementary notes

Values prior to 2020 were taken from previous annual reports.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Amgen "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Amgen

Overview

5

Financials

5

Products and regions

3

Competitors

4

Research and development

4

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

AmgenGlobal pharmaceutical industryBiotech drugsPfizerBiogen
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu